Exercise in All ChemoTherapy

Completed · Not applicable

Conditions studied: Chemotherapy, Exercise

In brief

Exercise in all Chemotherapy (EnACT) is a study to assess safety, feasibility, and acceptability of an exercise program within chemotherapy. This will be a single group study to capture the effects of an exercise intervention on the average chemotherapy patient and the patients compliance to the study.

Key facts

Study ID

NCT03461471

Run by

Milton S. Hershey Medical Center

People needed

168

Starts

2017-04-01

Expected to finish

2019-03-30

Last updated by the study team

2019-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females ≥18 years of age
• Fluent in written and spoken English
• Must be able to provide and understand informed consent
• Must have an ECOG PS of ≤ 2
• Diagnosed with a solid tumor malignancy
• Cancer patients (stage 1-4)
• Scheduled to receive chemotherapy at Penn State Cancer Institute
• Absence of absolute contraindications for exercise according to the American Heart Association
• Primary attending oncologist approval

You may not qualify if…

• Receiving chemotherapy at a location other than Penn State Cancer Institute
• Not fluent in written and spoken English
• Hematological malignancy
• Evidence in the medical record of an absolute contraindication for exercise
• Cardiac exclusion criteria:
• Class II, III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system
• History of acute coronary syndromes (including myocardial infarction and unstable angina), coronary angioplasty or stenting within the past 6 months prior to the start of chemotherapy
• Uncontrolled arrhythmias; patients with rate controlled atrial fibrillation for >1 month prior to start of chemotherapy may be eligible
• syncope
• acute myocarditis, pericarditis, or endocarditis
• acute pulmonary embolus or pulmonary infarction
• thrombosis of lower extremities
• suspected dissecting aneurysm
• pulmonary edema
• respiratory failure
• acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise
• mental impairment leading to inability to cooperate
• Non-English speaking
• Pregnant women
• Children (the protocol will only include individuals 18 and older)

Where it is running

• Penn State Cancer Institute — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.